Peter Lynch · Growth at a reasonable price (GARP)
Is Catalyst Pharmaceuticals, Inc. (CPRX) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
65/100
Mixto
6/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a CPRX
PEG ≤ 1.0
clave0.37
EPS CAGR ≥ 15%
clave46.5%
Revenue CAGR ≥ 10%
43.0%
Net margin > 0
37.1%
Cómo se valora CPRX en otras estrategias
Datos financieros en vivo
Cap. mercado
$3.85B
PER (TTM)
17.3x
ROIC (TTM)
19.67%
Margen bruto
82.32%
Otros análisis Peter Lynch
Preguntas frecuentes
What is CPRX's Peter Lynch fit score?
CPRX scores 65/100 on our Peter Lynch fit engine. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own CPRX?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends CPRX.
How often is this score updated?
CPRX's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende CPRX personalmente.
